Artal Group S.A. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$317
-98.9%
1,747
-98.8%
0.02%
-98.8%
Q4 2022$29,475
-99.9%
150,000
+20.0%
1.64%
+37.1%
Q3 2022$28,116,000
+646.4%
125,000
+150.0%
1.20%
+721.9%
Q4 2019$3,767,00050,0000.15%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders